# Vitestro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vitestro

- Industry: Medical Devices & Equipment
- Headquarters: Utrecht, Netherlands
- Website: www.vitestro.com
- Total disclosed funding: $84M
- Latest round: Series B (Mar 1, 2026)
- Investors on record: 12

## About

Based in the Netherlands, Vitestro B.V., aka Vitestro develops autonomous robotic blood-collection systems, using AI and robotics to automate phlebotomy, improving efficiency, consistency, and patient experience. Based in Utrecht, Netherlands, and founded in 2017 by co-founders Toon Overbeeke and Brian Joseph Vitestro B.V., aka Vitestro developer of a medical robotic device for use in hospitals and clinical laboratories to prevent arterial complications in clinical practice. In March 2026, Vitestro raised EUR 60 million in series B funding from LabCorp Ventures, Mayo Clinic Ventures, MGFO Private Investment, PGGM, Puma Venture Capital, ROM Utrecht Region, Sutter Health, Sonder Capital, European Innovation Council, Invest-NL, and NYBC Ventures. Vitestro offers Aletta, an autonomous robotic phlebotomy device that uses AI, imaging, and robotics to perform blood draws, supported by clinical validation, regulatory approval, deployment services, and partnerships with hospitals to improve efficiency, consistency, staffing utilization, and patient experience worldwide. Vitestro generates revenue by selling and deploying its Aletta autonomous robotic phlebotomy systems to hospitals and laboratories, supplemented by recurring income from service contracts, maintenance, training, clinical support, and long-term partnerships supporting adoption, regulatory compliance, and operational integration. The company plans to use the March 2026 funding to develop the next-generation Aletta robotic phlebotomy device, support FDA De?Novo approval, and scale manufacturing and commercial operations.

## Funding rounds

- Series B, Mar 1, 2026, $71M — Mayo Clinic Ventures, PGGM, InterVest, Sutter Health, LabCorp Ventures, Sonder Capital, Invest-NL, ROM Utrecht Region, NYBC Ventures, Puma Venture Capital, European Innovation Council, MGFO Private Investments
- Series A, Mar 21, 2023, $13M — Sonder Capital

## Investors

- Sonder Capital (https://capitalatlas.ai/funds/sonder-capital) — Series A, Series B
- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Series B
- PGGM — Series B
- InterVest (https://capitalatlas.ai/funds/intervest) — Series B
- Sutter Health — Series B
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series B
- Invest-NL — Series B
- ROM Utrecht Region (https://capitalatlas.ai/funds/rom-utrecht-region) — Series B
- NYBC Ventures (https://capitalatlas.ai/funds/nybc-ventures) — Series B
- Puma Venture Capital (https://capitalatlas.ai/funds/puma-venture-capital) — Series B
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series B
- MGFO Private Investments — Series B